Stay updated on Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial
Sign up to get notified when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.

Latest updates to the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov page now displays the NRP104 study record, including its overview, eligibility criteria, study plan, and record history, instead of a 403 error.SummaryDifference42%

- Check13 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA site-wide NIH notice about terminology changes appears above the ClinicalTrials.gov 403 error page. The footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link. This replaces the study's detailed content and the previously listed MeSH terms on the page.SummaryDifference17%

- Check62 days agoChange DetectedThe page shows a revision update from v3.6.6 to v3.7.0, indicating a system/template version upgrade. This change does not modify the trial details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.